Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

Recruiting

• Conditions: Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm
• Interventions: Other: Questionnaire Administration

• Registration Number: NCT05054413
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.

Detailed Description

PRIMARY OBJECTIVE:

I. To formulate consensus agreement on a minimum set of clinical key elements that should be included in standardized reports in electronic health records when managing patients with prostate cancer.

OUTLINE:

Participants complete 3-4 rounds of questionnaires over 20-30 minutes each over 2 weeks.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2021-03-21
• Study Start: 2021-04-15
• Study First Submitted QC: 2021-09-22
• Study First Posted: 2021-09-23
• Status Verified: 2024-10
• Last Update Submitted: 2024-10-28
• Last Update Posted: 2024-10-31
• Primary Completion: 2026-05-01
• Study Completion: 2026-05-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Age 21 and above
• Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
• Maintenance of an active practice that includes prostate cancer patients
• English speaking

Read More

Exclusion Criteria

• Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer
• Prisoners, children, and adults unable to consent to participation will also be excluded
• No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Observational (questionnaire)	Questionnaire Administration	Participants complete 3-4 rounds of questionnaires over 20-30 minutes each over 2 weeks.

Primary Outcome Measures

Name	Time	Method
To establish a standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivor-ship.	through study completion, an average of a year.

Trial Locations

Locations (1)

M D Anderson Cancer Center; 🇺🇸 Houston, Texas, United States